(Q33495298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

review article

1 reference

title

Comparative adverse effect profiles of platinum drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

M J McKeage

series ordinal

1

1 reference

27 July 2017

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

228-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573296%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-199513040-00003

14 October 2019

exact match

0 references

cites work

High-dose cisplatin treatment: hearing loss and plasma concentrations.

1 reference

12 December 2020

Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents

1 reference

12 December 2020

Ototoxicity of the anticancer drug cisplatin. An experimental study.

1 reference

12 December 2020

Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model

1 reference

12 December 2020

Cisplatin/carboplatin cross-resistance in ovarian cancer

1 reference

12 December 2020

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

1 reference

12 December 2020

Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics

1 reference

12 December 2020

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

1 reference

12 December 2020

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug

1 reference

12 December 2020

Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline

1 reference

12 December 2020

The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer

1 reference

12 December 2020

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

12 December 2020

Clinical pharmacology of high-dose cisplatin

1 reference

12 December 2020

Human pharmacokinetics of carboplatin after oral administration

1 reference

12 December 2020

Cisplatin neurotoxicity

1 reference

12 December 2020

Acute nephrotoxicity following cis-dichlorodiammine-platinum

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

1 reference

12 December 2020

Cis-dichlorodiammineplatinum (II) (NSC-119875): hearing loss and other toxic effects in rhesus monkeys

1 reference

12 December 2020

cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.

1 reference

12 December 2020

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

1 reference

12 December 2020

Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo

1 reference

12 December 2020

Clinical Pharmacokinetics of Carboplatin

1 reference

12 December 2020

Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

12 December 2020

Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig

1 reference

12 December 2020

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

1 reference

12 December 2020

Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity

1 reference

12 December 2020

Reduction of carboplatin induced emesis by ondansetron

1 reference

12 December 2020

Comparative distribution and excretion of carboplatin and cisplatin in mice.

1 reference

12 December 2020

Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity

1 reference

12 December 2020

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

1 reference

12 December 2020

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity

1 reference

12 December 2020

Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti.

1 reference

12 December 2020

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

1 reference

12 December 2020

Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.

1 reference

12 December 2020

Carboplatin: the clinical spectrum to date

1 reference

12 December 2020

Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs

1 reference

12 December 2020

Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.

1 reference

12 December 2020

Inner ear histopathology in patients treated with cis-platinum.

1 reference

12 December 2020

Mechanism of cisplatin nephrotoxicity

1 reference

12 December 2020

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

1 reference

12 December 2020

Cisplatin ototoxicity in gynecologic cancer patients. A preliminary report.

1 reference

12 December 2020

Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat

1 reference

12 December 2020

Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.

1 reference

12 December 2020

Metal compounds in therapy and diagnosis

1 reference

12 December 2020

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

12 December 2020

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions

1 reference

12 December 2020

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

1 reference

12 December 2020

Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).

1 reference

12 December 2020

The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin

1 reference

12 December 2020

Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial

1 reference

12 December 2020

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

12 December 2020

A study of the protective effect of chloride salts on cisplatin nephrotoxicity

1 reference

12 December 2020

Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats

1 reference

12 December 2020

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

12 December 2020

Current controversies in the management of testicular cancer

1 reference

12 December 2020

Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity

1 reference

12 December 2020

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

High-dose cisplatin in patients with advanced malignancies.

1 reference

12 December 2020

The effect of cisplatin on renal ATPase activity in vivo and in vitro

1 reference

12 December 2020

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

1 reference

12 December 2020

Severe nephrotoxicity: a probable complication of cis-dichlorodiammineplatinum (II) and cephalothin-gentamicin therapy

1 reference

12 December 2020

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy

1 reference

12 December 2020

Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum

1 reference

12 December 2020

Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds

1 reference

12 December 2020

Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.

1 reference

12 December 2020

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

1 reference

12 December 2020

Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity

1 reference

12 December 2020

Long-term sequelae of treatment for testicular germ cell tumours

1 reference

12 December 2020

A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration

1 reference

12 December 2020

Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients.

1 reference

12 December 2020

Protective effects of glutathione on cisplatin neurotoxicity in rats

1 reference

12 December 2020

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

1 reference

12 December 2020

Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: effect of the neuroprotecting peptide ORG.2766.

1 reference

12 December 2020

The effect of carboplatin on renal function in patients with metastatic germ cell tumours

1 reference

12 December 2020

Cis-platinum ototoxicity: clinical experience and temporal bone histopathology.

1 reference

12 December 2020

Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate

1 reference

12 December 2020

cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting.

1 reference

12 December 2020

Cisplatin neurotoxicity

1 reference

12 December 2020

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities

1 reference

12 December 2020

The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats

1 reference

12 December 2020

Neurotoxic side-effects of cisplatin

1 reference

12 December 2020

Hyperuricemia and hypoalbuminemia predispose to cisplatin-induced nephrotoxicity

1 reference

12 December 2020

Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs.

1 reference

12 December 2020

Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin

1 reference

12 December 2020

Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.

1 reference

12 December 2020

Ototoxicity of low- and moderate-dose cisplatin

1 reference

12 December 2020

Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations

1 reference

12 December 2020

Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies

1 reference

12 December 2020

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Cisplatin nephrotoxicity. A review

1 reference

12 December 2020

Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man

1 reference

12 December 2020

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

12 December 2020

Prediction of carboplatin clearance from standard morphological and biological patient characteristics

1 reference

12 December 2020

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

12 December 2020

Carboplatin is ototoxic.

1 reference

12 December 2020

Comparison of methods of evaluating nephrotoxicity of cis-platinum

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin

1 reference

12 December 2020

Ifosfamide and exacerbation of cisplatin-induced hearing loss

1 reference

12 December 2020

Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B study

1 reference

12 December 2020

The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

The ototoxic mechanism of cisplatin

1 reference

12 December 2020

Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA

1 reference

12 December 2020

Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer

1 reference

12 December 2020

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

1 reference

12 December 2020

The late effects of cis-platinum on renal function

1 reference

12 December 2020

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

1 reference

12 December 2020

Reduced glutathione protects against cisplatin-induced neurotoxicity in rats

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

1 reference

12 December 2020

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride

1 reference

12 December 2020

Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice

1 reference

12 December 2020

The inhibition of renal ATPase by cisplatin and some bio-transformation products

1 reference

12 December 2020

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

1 reference

12 December 2020

Serotonin antagonists: a new class of antiemetic agents

1 reference

12 December 2020

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

1 reference

12 December 2020

Minamata disease: an unusual neurological disorder caused by contaminated fish

1 reference

12 December 2020

Allergic reactions to carboplatin

1 reference

12 December 2020

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

1 reference

12 December 2020

Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer

1 reference

12 December 2020

Cisplatin nephrotoxicity

1 reference

12 December 2020

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

12 December 2020

Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

12 December 2020

Hypersensitivity reactions to cisplatin and carboplatin--a report on six cases

1 reference

12 December 2020